Should President-elect Donald Trump follow through on his threat to use tariffs as a wedge to pry Greenland from Denmark, it could result in higher prices for the popular weight-loss drug Ozempic in the U.S., according to reports.
Earlier this week, Trump said he would impose “very high” tariffs on Denmark if it didn’t sell Greenland to the U.S. The island, a self-governing territory within Denmark’s kingdom, has resurfaced on Trump’s wish list ahead of his new administration.
And while Denmark is not a major trading partner, the U.S. did import $5.7 billion worth of pharmaceuticals from the country in 2023 — a figure that was even higher in 2024 — because Danish pharmaceutical giant Novo Nordisk is the sole owner of semaglutide, the chief ingredient in Ozempic and its sister drug, Wegovy, CNN reported. The drugs fight diabetes but have soared in popularity for their weight-loss effects.
Read more at Newsmax© 2025 Newsmax. All rights reserved.
